Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Prevalence of apparent treatment-resistant hypertension among individuals with CKD.

Tanner RM, Calhoun DA, Bell EK, Bowling CB, Gutiérrez OM, Irvin MR, Lackland DT, Oparil S, Warnock D, Muntner P.

Clin J Am Soc Nephrol. 2013 Sep;8(9):1583-90. doi: 10.2215/CJN.00550113. Epub 2013 Jul 18.

2.

Kidney Function Decline and Apparent Treatment-Resistant Hypertension in the Elderly.

Kaboré J, Metzger M, Helmer C, Berr C, Tzourio C, Massy ZA, Stengel B.

PLoS One. 2016 Jan 25;11(1):e0146056. doi: 10.1371/journal.pone.0146056. eCollection 2016.

3.

Apparent Treatment-resistant Hypertension Among Individuals with History of Stroke or Transient Ischemic Attack.

Howard VJ, Tanner RM, Anderson A, Irvin MR, Calhoun DA, Lackland DT, Oparil S, Muntner P.

Am J Med. 2015 Jul;128(7):707-14.e2. doi: 10.1016/j.amjmed.2015.02.008. Epub 2015 Mar 10.

4.
5.

The association of chronic kidney disease complications by albuminuria and glomerular filtration rate: a cross-sectional analysis.

Viswanathan G, Sarnak MJ, Tighiouart H, Muntner P, Inker LA.

Clin Nephrol. 2013 Jul;80(1):29-39.

6.

Incident ESRD and treatment-resistant hypertension: the reasons for geographic and racial differences in stroke (REGARDS) study.

Tanner RM, Calhoun DA, Bell EK, Bowling CB, Gutiérrez OM, Irvin MR, Lackland DT, Oparil S, McClellan W, Warnock DG, Muntner P.

Am J Kidney Dis. 2014 May;63(5):781-8. doi: 10.1053/j.ajkd.2013.11.016. Epub 2014 Jan 1. Review.

7.

Midlife Blood Pressure and Late-Life GFR and Albuminuria: An Elderly General Population Cohort.

Inker LA, Okparavero A, Tighiouart H, Aspelund T, Andresdottir MB, Eiriksdottir G, Harris T, Launer L, Nikulasdottir H, Sverrisdottir JE, Gudmundsdottir H, Noubary F, Mitchell G, Palsson R, Indridason OS, Gudnason V, Levey AS.

Am J Kidney Dis. 2015 Aug;66(2):240-8. doi: 10.1053/j.ajkd.2015.03.030. Epub 2015 May 16.

8.

CKD and cardiovascular disease in the Atherosclerosis Risk in Communities (ARIC) study: interactions with age, sex, and race.

Hui X, Matsushita K, Sang Y, Ballew SH, Fülöp T, Coresh J.

Am J Kidney Dis. 2013 Oct;62(4):691-702. doi: 10.1053/j.ajkd.2013.04.010. Epub 2013 Jun 13.

9.

Hypertension control and antihypertensive therapy in patients with chronic kidney disease.

Unni S, White K, Goodman M, Ye X, Mavros P, Bash LD, Brixner D.

Am J Hypertens. 2015 Jun;28(6):814-22. doi: 10.1093/ajh/hpu215. Epub 2014 Nov 24.

PMID:
25421796
10.

Geographic variation in CKD prevalence and ESRD incidence in the United States: results from the reasons for geographic and racial differences in stroke (REGARDS) study.

Tanner RM, Gutiérrez OM, Judd S, McClellan W, Bowling CB, Bradbury BD, Safford MM, Cushman M, Warnock D, Muntner P.

Am J Kidney Dis. 2013 Mar;61(3):395-403. doi: 10.1053/j.ajkd.2012.10.018. Epub 2012 Dec 8.

11.

Blood pressure and antihypertensive medication profile in a multiethnic Asian population of stable chronic kidney disease patients.

Teo BW, Chua HR, Wong WK, Haroon S, Subramanian S, Loh PT, Sethi S, Lau T.

Singapore Med J. 2016 May;57(5):267-73. doi: 10.11622/smedj.2016089.

12.

Refractory hypertension: determination of prevalence, risk factors, and comorbidities in a large, population-based cohort.

Calhoun DA, Booth JN 3rd, Oparil S, Irvin MR, Shimbo D, Lackland DT, Howard G, Safford MM, Muntner P.

Hypertension. 2014 Mar;63(3):451-8. doi: 10.1161/HYPERTENSIONAHA.113.02026. Epub 2013 Dec 9.

13.

Nondisease-specific problems and all-cause mortality among older adults with CKD: the REGARDS Study.

Bowling CB, Booth JN 3rd, Gutiérrez OM, Kurella Tamura M, Huang L, Kilgore M, Judd S, Warnock DG, McClellan WM, Allman RM, Muntner P.

Clin J Am Soc Nephrol. 2014 Oct 7;9(10):1737-45. doi: 10.2215/CJN.00880114. Epub 2014 Oct 2.

14.

Prevalence and Prognostic Significance of Apparent Treatment Resistant Hypertension in Chronic Kidney Disease: Report From the Chronic Renal Insufficiency Cohort Study.

Thomas G, Xie D, Chen HY, Anderson AH, Appel LJ, Bodana S, Brecklin CS, Drawz P, Flack JM, Miller ER 3rd, Steigerwalt SP, Townsend RR, Weir MR, Wright JT Jr, Rahman M; CRIC Study Investigators.

Hypertension. 2016 Feb;67(2):387-96. doi: 10.1161/HYPERTENSIONAHA.115.06487. Epub 2015 Dec 28.

15.

Sex differences in hypertension-related renal and cardiovascular diseases in Italy: the I-DEMAND study.

Muiesan ML, Ambrosioni E, Costa FV, Leonetti G, Pessina AC, Salvetti M, Trimarco B, Volpe M, Pontremoli R, Deferrari G, Rosei EA.

J Hypertens. 2012 Dec;30(12):2378-86. doi: 10.1097/HJH.0b013e328359b6a9.

PMID:
23137952
16.

Error occurred: cannot get document summary

PMID:
29054846

17.

Association of chronic kidney disease with atrial fibrillation among adults in the United States: REasons for Geographic and Racial Differences in Stroke (REGARDS) Study.

Baber U, Howard VJ, Halperin JL, Soliman EZ, Zhang X, McClellan W, Warnock DG, Muntner P.

Circ Arrhythm Electrophysiol. 2011 Feb;4(1):26-32. doi: 10.1161/CIRCEP.110.957100. Epub 2010 Nov 13.

18.

Development and validation of a model to predict 5-year risk of death without ESRD among older adults with CKD.

Bansal N, Katz R, De Boer IH, Peralta CA, Fried LF, Siscovick DS, Rifkin DE, Hirsch C, Cummings SR, Harris TB, Kritchevsky SB, Sarnak MJ, Shlipak MG, Ix JH.

Clin J Am Soc Nephrol. 2015 Mar 6;10(3):363-71. doi: 10.2215/CJN.04650514. Epub 2015 Feb 20.

19.

Blood pressure and chronic kidney disease progression in a multi-racial cohort: the Multi-Ethnic Study of Atherosclerosis.

Bloomfield GS, Yi SS, Astor BC, Kramer H, Shea S, Shlipak MG, Post WS.

J Hum Hypertens. 2013 Jul;27(7):421-6. doi: 10.1038/jhh.2013.1. Epub 2013 Feb 14.

20.

Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality.

Peralta CA, Shlipak MG, Judd S, Cushman M, McClellan W, Zakai NA, Safford MM, Zhang X, Muntner P, Warnock D.

JAMA. 2011 Apr 20;305(15):1545-52. doi: 10.1001/jama.2011.468. Epub 2011 Apr 11.

Supplemental Content

Support Center